Education
About Us
Working with TipRanks
Follow Us
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
GTHP Stock Chart & Stats
$0.35
>-$0.01(-1.55%)
At close: 4:00 PM EST
$0.35
>-$0.01(-1.55%)
Day’s Range― - ―
52-Week Range$0.06 - $0.32
Previous CloseN/A
Volume813.00
Average Volume (3M)12.33K
Market Cap
$29.26M
Enterprise Value$21.89M
Total Cash (Recent Filing)$87.00K
Total Debt (Recent Filing)$2.37M
Price to Earnings (P/E)―
Beta1.73
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding83,599,160
10 Day Avg. Volume11,951
30 Day Avg. Volume12,334
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)-1.76
Price to Sales (P/S)1228.69
P/FCF Ratio-7.69
Enterprise Value/Market Cap0.75
Enterprise Value/Revenue185.48
Enterprise Value/Gross Profit251.57
Enterprise Value/Ebitda-11.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GTHP FAQ
What was Guided Therapeutics Inc’s price range in the past 12 months?
Guided Therapeutics Inc lowest stock price was $0.06 and its highest was $0.32 in the past 12 months.
What is Guided Therapeutics Inc’s market cap?
Guided Therapeutics Inc’s market cap is $29.26M.
When is Guided Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Guided Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Guided Therapeutics Inc overvalued?
According to Wall Street analysts Guided Therapeutics Inc’s price is currently Overvalued.
Does Guided Therapeutics Inc pay dividends?
Guided Therapeutics Inc does not currently pay dividends.
What is Guided Therapeutics Inc’s EPS estimate?
Guided Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guided Therapeutics Inc have?
Guided Therapeutics Inc has 83,599,160 shares outstanding.
What happened to Guided Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Guided Therapeutics Inc?
Currently, no hedge funds are holding shares in GTHP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Guided Therapeutics Inc
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Technical Analysis
Co-Diagnostics
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Movano
―
Nexalin Technology, Inc.
―
Ownership Overview
Options Prices
Currently, No data available
---